# Ubaifu

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ubaifu

- Industry: Biotechnology
- Headquarters: Fuzhou, China
- Latest round: Series A (Dec 5, 2017)
- Investors on record: 2

## About

Established in 2013 and based in Shanghai, China, Ubaifu is a biopharmaceutical company that engages in the development and sales of pharmaceutical raw materials and nutritional raw materials.

The company’s main business is the research and development of innovative pharmaceutical and nutritional raw materials, focusing on bio-fermentation technology. The company’s self-developed products include Gamma-Aminobutyric Acid (GABA), Pyrroloquinoline Quinone (PQQ), Astaxanthin, and Coenzyme Q10. These products are widely used in the fields of pharmaceuticals, nutritional supplements, food additives, and feed additives.

The company generates revenue by providing raw materials and services to the pharmaceutical, nutritional supplements, food and feed additives industries.

## Funding rounds

- Series A, Dec 5, 2017 — Yangming Capital, Fukang Pharmaceutical

## Investors

- Yangming Capital — Series A
- Fukang Pharmaceutical — Series A